Connect Biopharma Holdings Limited (CNTB)
CNTB trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.9188
+1.45% on the day
Market cap
$57.9M
Micro cap
Revenue · 2025
$64K
-99.8% on 2024
Net income · 2025
-$55.5M
-86687.5% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | CNTB on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | China |
| IPO year | 2021 |
| SEC CIK | 0001835268 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | E9 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $64K |
| Net income | -$55.5M |
| Operating income | -$58.1M |
| Net margin | -86687.5% |
| Operating margin | -90740.6% |
| Revenue growth | -99.8% |
| Cash | $38.3M |
| Total assets | $56.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 904.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | F-3 | 2026-05-15 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-08-12 |
| Latest current report | 8-K | 2026-09-30 |
Source: SEC EDGAR submissions feed, 195 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BOLD | Boundless Bio Inc. | $2.43 | -4.71% | $56.2M |
| GOSS | Gossamer Bio Inc. | $9.76 | +5.17% | $59.7M |
| TENX | Tenax Therapeutics Inc. | $1.60 | -12.57% | $59.9M |
| PLRX | Pliant Therapeutics Inc. | $0.9680 | -1.83% | $59.9M |
| TLPH | Talphera Inc. | $1.07 | -0.93% | $55.5M |
| XLO | Xilio Therapeutics Inc. | $9.22 | +1.60% | $60.7M |
| VRCA | Verrica Pharmaceuticals Inc. | $3.58 | -10.72% | $61.5M |
| GANX | Gain Therapeutics Inc. | $1.41 | -10.19% | $61.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier